Cinemark Holdings, Inc. — 2023 Form 10-K Summary
Business context and reporting period
The filing covers the fiscal year ended December 31, 2023, rather than the fourth quarter alone; the provided filing text does not give a clear standalone Q4 financial breakdown. Cinemark operates movie theatres in the U.S. and Latin America through U.S. and international reporting segments. At year-end it operated 501 theatres and 5,719 screens in 13 Latin American countries and 42 U.S. states. Holdings is a holding company; substantially all operations are conducted through wholly owned Cinemark USA, Inc. (CUSA).
Financial and operating performance
| Metric | FY 2023 | FY 2022 | Change / context |
|---|---|---|---|
| Total revenue | $3,066.7 million | $2,454.7 million | Up 24.9% |
| Operating income (loss) | $362.9 million | $(89.8) million | Operating margin 11.8%; prior year loss |
| Net income (loss) | $191.5 million | $(268.0) million | Net income attributable to Holdings: $188.2 million, or $1.55 basic and $1.34 diluted EPS |
| Adjusted EBITDA | $594.1 million | $336.5 million | Up from prior year; approximately 19.4% of revenue |
| Cash provided by operating activities | $444.3 million | $136.0 million | Holdings consolidated |
| Capital expenditures | $149.5 million | $110.7 million | Operating cash flow less capex was approximately $294.8 million |
| Cash and cash equivalents | $849.1 million | $674.5 million | Holdings consolidated; CUSA reported $612.4 million |
| Long-term debt carrying value | $2,432.1 million | $2,516.6 million | Includes Holdings’ $460 million convertible notes; excludes unamortized costs and discounts |
Revenue gains reflected increased attendance and higher per-patron spending. Attendance rose 21.5% to 209.8 million; average ticket price increased 2.6% to $7.41 and concession revenue per patron rose 4.6% to $5.68. U.S. revenue increased 22.6%; international revenue increased 34.4% as reported (65.8% in constant currency). The international results were affected by currency movements.
At December 31, 2023, current assets were $1,060.0 million and current liabilities were $730.3 million, implying working capital of approximately $329.7 million. The $125 million revolving facility was undrawn, leaving $125 million of stated borrowing capacity. Management said existing cash and expected operating cash flows should cover working capital, capital expenditures, and known contractual obligations for the next 12 months and beyond. This assessment is subject to the risks and restrictions described in the filing.
Debt reduction included redeeming $100 million of 8.75% secured notes for $106.6 million in cash. CUSA’s amended credit facility had $645.1 million outstanding on its term loan and no revolver borrowings at year-end; the term loan’s average rate after swaps was approximately 7.1%. Holdings also had $87.8 million of finance lease obligations and $853.3 million of long-term operating lease obligations, plus current lease liabilities.
Material changes versus the prior comparable period
- Revenue grew 24.9%, and the company moved from an operating loss and net loss in 2022 to operating and net income in 2023.
- Operating cash flow rose to $444.3 million from $136.0 million. Capital expenditures increased to $149.5 million, primarily reflecting continued recovery and investment in existing theatres.
- Impairment charges fell to $16.6 million from $174.1 million. The 2023 charge included $15.9 million for theatre assets and $0.7 million related to NCMI; the 2022 charge included a $113.2 million NCM impairment.
- Interest income increased to $55.0 million from $20.4 million, while interest expense declined to $150.4 million from $155.3 million. Foreign currency exchange and other related losses increased to $28.8 million from $11.5 million.
Outlook, commentary, risks, and unusual items
Cinemark gave no specific financial guidance in the provided filing text. Management’s outlook depends heavily on the volume, timing, and performance of theatrical releases, release windows, and consumer attendance. The company cited a 2024 film slate but cautioned that the 2023 writers’ and actors’ strikes delayed production and are expected to reduce film availability in 2024, with some releases pushed to 2025 or 2026. Management noted that North American box office revenue was preliminarily estimated at approximately $9.1 billion in 2023, up more than 21% year over year.
- Industry and operating risks: Dependence on successful film releases and studio relationships; competition from streaming and other entertainment; seasonality; inflation in wages, food, and operating costs; labor availability; and potential changes to theatrical release windows.
- Debt and liquidity: Significant debt and long-term lease commitments, upcoming debt maturities, variable-rate exposure, covenant restrictions, and non-investment-grade debt ratings. Approximately $617.7 million of debt was scheduled to mature in 2025, including Holdings’ convertible notes and CUSA secured notes.
- Foreign exchange: Exposure to Latin American currencies and exchange controls. Argentina is treated as highly inflationary; Blue Chip Swap transactions generated a $12.4 million loss in 2023.
- NCM: National CineMedia (NCM) filed for Chapter 11 in April 2023 and emerged in August. Cinemark’s ownership fell below 5%, it lost board designation rights, and it changed its investment accounting. The company recorded a $12.4 million unrealized gain on NCMI shares. An appeal concerning Cinemark’s most-favored-nations rights under its exhibitor services agreement remained unresolved.
- Other notable items: A $10.7 million loss on debt extinguishment and refinancing; a $6.9 million gain on the sale of the Ecuador subsidiary; and the continued suspension of Holdings’ dividend, suspended in March 2020.
- Contingencies: Cinemark’s COVID-19 insurance coverage lawsuit was appealed after the district court granted summary judgment to the insurer. The company also disclosed a class action alleging violations of the Fair and Accurate Credit Transactions Act. Management stated that ordinary-course proceedings were not expected to be material overall, but outcomes of identified cases could not be predicted.
Important facts for investors to verify
- Review the full financial statements and notes for the exact cash, debt, lease, and near-term maturity profile; note that Holdings and CUSA have different cash and debt balances.
- Track film release schedules, attendance, ticket pricing, concession spending, and whether strike-related content delays constrain 2024 results.
- Assess debt refinancing and repayment plans, including 2025 maturities, floating-rate exposure, covenant headroom, and restrictions on dividends or transfers from CUSA to Holdings.
- Monitor NCM’s post-bankruptcy performance, Cinemark’s advertising economics, and the outcome of the appeal over its contractual rights.
- Review foreign currency exposure, especially Argentina’s exchange controls and the impact of local-currency movements on reported results and cash access.